These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33537526)

  • 21. Protease-activated receptors: contribution to physiology and disease.
    Ossovskaya VS; Bunnett NW
    Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of platelet activation by thrombin: a short history.
    De Candia E
    Thromb Res; 2012 Mar; 129(3):250-6. PubMed ID: 22137742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Concept of Action of Hemostatic Proteases on Inflammation, Neurotoxicity, and Tissue Regeneration.
    Gorbacheva LR; Kiseleva EV; Savinkova IG; Strukova SM
    Biochemistry (Mosc); 2017 Jul; 82(7):778-790. PubMed ID: 28918742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells.
    Colognato R; Slupsky JR; Jendrach M; Burysek L; Syrovets T; Simmet T
    Blood; 2003 Oct; 102(7):2645-52. PubMed ID: 12805069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1).
    Maryanoff BE; Zhang HC; Andrade-Gordon P; Derian CK
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):13-36. PubMed ID: 15317288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy.
    Cunningham M; McIntosh K; Bushell T; Sloan G; Plevin R
    Biochem Soc Trans; 2016 Apr; 44(2):606-12. PubMed ID: 27068977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1).
    Mihara K; Ramachandran R; Renaux B; Saifeddine M; Hollenberg MD
    J Biol Chem; 2013 Nov; 288(46):32979-90. PubMed ID: 24052258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Physiology of protease-activated receptors (PARs): involvement of PARs in digestive functions].
    Kawabata A; Kuroda R; Hollenberg MD
    Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():173P-179P. PubMed ID: 10629876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.
    Driesbaugh KH; Buzza MS; Martin EW; Conway GD; Kao JP; Antalis TM
    J Biol Chem; 2015 Feb; 290(6):3529-41. PubMed ID: 25519908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonists and antagonists of protease activated receptors (PARs).
    Barry GD; Le GT; Fairlie DP
    Curr Med Chem; 2006; 13(3):243-65. PubMed ID: 16475935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease-activated receptors: a means of converting extracellular proteolysis into intracellular signals.
    Mackie EJ; Pagel CN; Smith R; de Niese MR; Song SJ; Pike RN
    IUBMB Life; 2002 Jun; 53(6):277-81. PubMed ID: 12625364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease-activated receptor signalling by coagulation proteases in endothelial cells.
    Rezaie AR
    Thromb Haemost; 2014 Nov; 112(5):876-82. PubMed ID: 24990498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of proteinase-activated receptor 1 antagonists as therapeutic agents for thrombosis, restenosis and inflammatory diseases.
    Ahn HS; Chackalamannil S; Boykow G; Graziano MP; Foster C
    Curr Pharm Des; 2003; 9(28):2349-65. PubMed ID: 14529396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin-Induced Calpain Activation Promotes Protease-Activated Receptor 1 Internalization.
    Alvarez-Arce A; Lee-Rivera I; López E; Hernández-Cruz A; López-Colomé AM
    Int J Cell Biol; 2017; 2017():1908310. PubMed ID: 29250115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis.
    Cornelissen I; Palmer D; David T; Wilsbacher L; Concengco C; Conley P; Pandey A; Coughlin SR
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18605-10. PubMed ID: 20930120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells.
    Rohani MG; Beyer RP; Hacker BM; Dommisch H; Dale BA; Chung WO
    Innate Immun; 2010 Apr; 16(2):104-14. PubMed ID: 19567485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease activated receptors in cardiovascular function and disease.
    Barnes JA; Singh S; Gomes AV
    Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease-activated receptors: regulation of neuronal function.
    Saito T; Bunnett NW
    Neuromolecular Med; 2005; 7(1-2):79-99. PubMed ID: 16052040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
    Miike S; McWilliam AS; Kita H
    J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.